Featured Research

from universities, journals, and other organizations

Antibiotics as active mutagens in the emergence of multidrug resistance

Date:
February 12, 2010
Source:
Cell Press
Summary:
Multidrug resistant bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) pose a major problem for patients, doctors, and the pharmaceutical industry. To combat such bacteria, it is critical to understand how resistance is developed in the first place. New research shows that low doses of antibiotics can produce mutant strains that are sensitive to the applied antibiotic but have cross-resistance to other antibiotics.

Multidrug resistant bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) pose a major problem for patients, doctors, and the pharmaceutical industry. To combat such bacteria, it is critical to understand how resistance is developed in the first place. It is commonly thought that an incomplete course of antibiotics would lead to resistance to that particular antibiotic by allowing the bacteria to make adaptive changes under less stringent conditions.

However, new research from Mike Kohanski, Mark DePristo, and Jim Collins at Boston University and the Howard Hughes Medical Institute shows that low doses of antibiotics can produce mutant strains that are sensitive to the applied antibiotic but have cross-resistance to other antibiotics. Their findings shed light on one of multiple mechanisms that may contribute to the emergence of multidrug resistant bacterial strains or so called "superbugs."

The study, published in the February 12th issue of Molecular Cell, a Cell Press journal, builds on earlier observations from this group that antibiotics produce reactive oxygen species (ROS) in bacteria. At high doses, ROS ultimately kill the bacteria, but at low doses they can lead to mutations. To test the hypothesis that low dose antibiotics might contribute to drug resistance through increased mutagenesis, they first confirmed that each of the antibiotics tested actually increased mutations in a manner that was dependent on the ability of the bacteria to produce reactive oxygen species.

This indeed proved to be the case, so they turned their attention to examining cross-resistance to other antibiotics. While each of the antibiotics tested (ampicillin, norfloxacin, kanamycin, tetracycline and chloramphenicol) is capable of some degree of cross-resistance, quite strikingly, ampicillin appears to give rise to the widest range of resistance. Surprisingly, the bacteria remained sensitive to the applied antibiotic. The observed resistance in each case is dependent on the ability of the bacteria to produce ROS, similar to the ability to produce mutations.

The researchers confirmed the link between antibiotic cross resistance and antibiotic-induced ROS by sequencing the bacterial genes known to cause resistance to each antibiotic, and in most cases they found mutations in the expected genes that would lead to the production of proteins that help the bacteria to endure the antibiotics (such as multidrug efflux pumps).

Importantly, this mutagenic mechanism occurs not only in laboratory strains of Escherichia coli and Staphylococcus aureus, but also in a clinical isolate of Escherichia coli showing that it is likely a general survival mechanism for bacteria. According to Collins, "our work shows that low levels of antibiotics can serve as active mutagens rapidly leading to multidrug resistance."

These findings have important implications in terms of both how antibiotics are administered and the potential benefits of combining antibiotic treatment with inhibitors that prevent the formation of ROS or that prevent the bacteria from generating mutations.

The researchers include Michael A. Kohanski, Howard Hughes Medical Institute, Boston University, Boston, MA, Boston University School of Medicine, Boston, MA; Mark A. DePristo, Boston University, Boston, MA, Harvard University, Cambridge, MA; and James J. Collins, Howard Hughes Medical Institute, Boston University, Boston, MA, Boston University School of Medicine, Boston, MA, Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Antibiotics as active mutagens in the emergence of multidrug resistance." ScienceDaily. ScienceDaily, 12 February 2010. <www.sciencedaily.com/releases/2010/02/100211121754.htm>.
Cell Press. (2010, February 12). Antibiotics as active mutagens in the emergence of multidrug resistance. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2010/02/100211121754.htm
Cell Press. "Antibiotics as active mutagens in the emergence of multidrug resistance." ScienceDaily. www.sciencedaily.com/releases/2010/02/100211121754.htm (accessed April 16, 2014).

Share This



More Plants & Animals News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Change of Diet Helps Crocodile Business

Change of Diet Helps Crocodile Business

Reuters - Business Video Online (Apr. 16, 2014) Crocodile farming has been a challenge in Zimbabwe in recent years do the economic collapse and the financial crisis. But as Ciara Sutton reports one of Europe's biggest suppliers of skins to the luxury market has come up with an unusual survival strategy - vegetarian food. Video provided by Reuters
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Raw: Three Rare White Tiger Cubs Debut at Zoo

Raw: Three Rare White Tiger Cubs Debut at Zoo

AP (Apr. 16, 2014) The Buenos Aires Zoo debuted a trio of rare white Bengal tiger cubs on Wednesday. (April 16) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins